curcumin maintenance therapy ulcerative colitis randomized multicenter double-blind placebo-controlled trial pubmed ncbi abstract background aims curcumin biologically active phytochemical substance present turmeric pharmacologic actions benefit patients ulcerative colitis uc aim trial assess efficacy curcumin maintenance therapy patients quiescent ulcerative colitis uc methods eighty-nine patients quiescent uc recruited randomized double-blind multicenter trial curcumin prevention relapse forty-five patients received curcumin num breakfast num evening meal sulfasalazine sz mesalamine num patients received placebo sz mesalamine num months clinical activity index cai endoscopic index ei determined entry num months cai conclusion num month trial end num month follow-up results patients protocol violators num patients received curcumin num relapsed num months therapy num num num patients num placebo group relapsed num recurrence rates evaluated basis intention treat showed significant difference curcumin placebo num curcumin improved cai num ei num suppressing morbidity uc num month follow-up patients groups sz mesalamine additional patients curcumin group num patients placebo group relapsed conclusions curcumin promising safe medication maintaining remission patients quiescent uc studies curcumin strengthen findings 
